Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142 ☆
Titel:
Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142 ☆
Auteur:
André, T. Lonardi, S. Wong, K.Y.M. Lenz, H.-J. Gelsomino, F. Aglietta, M. Morse, M.A. Van Cutsem, E. McDermott, R. Hill, A. Sawyer, M.B. Hendlisz, A. Neyns, B. Abdullaev, S. Memaj, A. Lei, M. Dixon, M. Kopetz, S. Overman, M.J.